Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK.LN | ||||
| Company | Gsk Plc | ||||
| Price Information | |||||
| Exchange | LSE | ||||
| Open | 1,960.000 | ||||
| High | 1,968.500 | ||||
| Low | 1,940.000 | ||||
| Latest | 1,950.500 | ||||
| Change | -5.500 | ||||
| % Change | -0.28% | ||||
| Volume | 851,159,151 | ||||
| 20-Day Average Volume | 53,735,410 | ||||
| Previous Close | 1,956.000 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 2,082.996 | ||||
| 20-Day Raw Stochastic | 3.01% | ||||
| 20-Day Relative Strength | 39.02 | ||||
| Weighted Alpha | +32.83 | ||||
| Today's Opinion | 56% Buy | ||||
| Previous Opinion | 56% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.06% since 03/13/26 | ||||
| Low | 1,940.000 on 03/20/26 | ||||
| High | 2,053.000 on 03/16/26 | ||||
| 1-Month | |||||
| %Chg | -12.35% since 02/20/26 | ||||
| Low | 1,940.000 on 03/20/26 | ||||
| High | 2,222.000 on 02/26/26 | ||||
| 3-Month | |||||
| %Chg | +8.23% since 12/19/25 | ||||
| Low | 1,774.000 on 01/20/26 | ||||
| High | 2,282.000 on 02/18/26 | ||||
| 6-Month | |||||
| %Chg | +30.20% since 09/19/25 | ||||
| Low | 1,455.000 on 09/26/25 | ||||
| High | 2,282.000 on 02/18/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 78,977,364 | ||||
| Shares Outstanding, K | 4,011,232 | ||||
| Annual Sales | 32,667,000,000 | ||||
| Annual Net Income | 5,716,000,000 | ||||
| Last Quarter Sales | 8,618,000,000 | ||||
| Last Quarter Net Income | 636,000,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | 0.16 on 02/04/26 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | 0.180 on 02/19/26 | ||||
| Next Ex-Dividends Date | 02/19/26 | ||||
| Ratios | |||||
| Price/Earnings ttm | 14.21 | ||||